270 SYN-004, a Class A Beta-Lactamase Therapy for the Prevention of Antibiotic-Induced Disruption of Intestinal Microflora

Detalles Bibliográficos
Autores principales: Kaleko, Michael, Bristol, Andrew, Connelly, Sheila, Koski, Pertti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
IDWeek 2014 Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781800/
http://dx.doi.org/10.1093/ofid/ofu052.136
_version_ 1783295043051716608
author Kaleko, Michael
Bristol, Andrew
Connelly, Sheila
Koski, Pertti
author_facet Kaleko, Michael
Bristol, Andrew
Connelly, Sheila
Koski, Pertti
author_sort Kaleko, Michael
collection PubMed
description
format Online
Article
Text
id pubmed-5781800
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-57818002018-03-01 270 SYN-004, a Class A Beta-Lactamase Therapy for the Prevention of Antibiotic-Induced Disruption of Intestinal Microflora Kaleko, Michael Bristol, Andrew Connelly, Sheila Koski, Pertti Open Forum Infect Dis IDWeek 2014 Abstracts Oxford University Press 2014-12 2014-12 /pmc/articles/PMC5781800/ http://dx.doi.org/10.1093/ofid/ofu052.136 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America
spellingShingle IDWeek 2014 Abstracts
Kaleko, Michael
Bristol, Andrew
Connelly, Sheila
Koski, Pertti
270 SYN-004, a Class A Beta-Lactamase Therapy for the Prevention of Antibiotic-Induced Disruption of Intestinal Microflora
title 270 SYN-004, a Class A Beta-Lactamase Therapy for the Prevention of Antibiotic-Induced Disruption of Intestinal Microflora
title_full 270 SYN-004, a Class A Beta-Lactamase Therapy for the Prevention of Antibiotic-Induced Disruption of Intestinal Microflora
title_fullStr 270 SYN-004, a Class A Beta-Lactamase Therapy for the Prevention of Antibiotic-Induced Disruption of Intestinal Microflora
title_full_unstemmed 270 SYN-004, a Class A Beta-Lactamase Therapy for the Prevention of Antibiotic-Induced Disruption of Intestinal Microflora
title_short 270 SYN-004, a Class A Beta-Lactamase Therapy for the Prevention of Antibiotic-Induced Disruption of Intestinal Microflora
title_sort 270 syn-004, a class a beta-lactamase therapy for the prevention of antibiotic-induced disruption of intestinal microflora
topic IDWeek 2014 Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781800/
http://dx.doi.org/10.1093/ofid/ofu052.136
work_keys_str_mv AT kalekomichael 270syn004aclassabetalactamasetherapyforthepreventionofantibioticinduceddisruptionofintestinalmicroflora
AT bristolandrew 270syn004aclassabetalactamasetherapyforthepreventionofantibioticinduceddisruptionofintestinalmicroflora
AT connellysheila 270syn004aclassabetalactamasetherapyforthepreventionofantibioticinduceddisruptionofintestinalmicroflora
AT koskipertti 270syn004aclassabetalactamasetherapyforthepreventionofantibioticinduceddisruptionofintestinalmicroflora

Ejemplares similares